Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1994
10/13/1994CA2158171A1 Hiv-1 vaccines, antibody compositions related thereto, and therapeutic and prophylactic uses thereof
10/13/1994CA2158056A1 Method of coupling ligands within porous supports (p.e. azlactone) and uses thereof
10/13/1994CA2157766A1 Analogs of peptide yy and uses thereof
10/13/1994CA2156641A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
10/13/1994CA2156620A1 Chelating agents of the type xn1s1o for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
10/13/1994CA2156619A1 Chelators agents of the type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/13/1994CA2156618A1 Bifunctional chelators and their use in radiopharmaceuticals
10/13/1994CA2136973A1 Recombinant timothy grass pollen allergen ph1 pii
10/12/1994EP0619372A1 Tumor necrosis factor muteins
10/12/1994EP0619371A1 Polypeptide derived from a glioblastoma cell line, its use and DNAs encoding it
10/12/1994EP0619370A1 Keratinocyte growth factor (KGF) for its use in method of therapeutic treatment for the human or animal body
10/12/1994EP0619322A2 Prolonged delivery of peptides
10/12/1994EP0619321A1 Very large scale immobilized peptide synthesis
10/12/1994EP0619118A1 Use of peptide derivatives
10/12/1994EP0618976A1 Synthetic dna sequence having enhanced insecticidal activity in maize
10/12/1994EP0618975A1 Dna, dna constructs, cells and plants derived therefrom
10/12/1994EP0618972A1 CONSTITUTIVE EXPRESSION OF P450SOY AND FERREDOXIN-SOY IN $i(STREPTOMYCES), AND BIOTRANSFORMATION OF CHEMICALS BY RECOMBINANT ORGANISMS
10/12/1994EP0618971A1 Method for refolding igf-i to active conformation
10/12/1994EP0618970A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof
10/12/1994EP0618968A1 Tools for the diagnosis and treatment of alzheimer's disease
10/12/1994EP0618967A1 Ifn-gamma antagonist cytokine
10/12/1994EP0618965A1 Method for generating structural and functional diversity in a peptide sequence
10/12/1994EP0618930A1 Monoclonal antibody to hiv-2 and uses thereof
10/12/1994EP0618929A1 Bispecific antibody heterodimers
10/12/1994EP0618927A1 Cytokines with an unpaired cysteine residue and conjugates thereof
10/12/1994EP0618926A1 New peptide derivatives
10/12/1994EP0618925A1 Gapped 2' modified oligonucleotides
10/12/1994EP0618923A1 Peptide nucleic acids and their effect on genetic material
10/12/1994EP0618814A1 Recombinant bovine herpesvirus type 1 polypeptides and vaccines
10/12/1994EP0618813A1 Antigen of hybrid m protein and carrier for group a streptococcal vaccine
10/12/1994EP0618812A1 Use of protease nexin-i as an antiinflammatory
10/12/1994EP0618811A1 Proteolytic mixture containing escharase and method of isolating same
10/12/1994EP0618807A1 A stabilized pharmaceutical formulation comprising growth hormone and histidine
10/12/1994EP0618804A1 Peptides corresponding to antigenic determinants of htlv
10/12/1994EP0618803A1 Cetp inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments
10/12/1994EP0618802A1 Synthetic compounds and compositions with enhanced cell binding
10/12/1994EP0555336A4 Homobifunctional agents for coupling enzymes and the like to antibodies and the like.
10/12/1994EP0546099B1 Use of human Interferon gamma 4-134
10/12/1994EP0494294B1 Bacterial stress proteins
10/12/1994EP0487619B1 Von casein-beta ausgehendes verfahren zur herstellung von fraktionen, die mit biologisch aktiven peptiden angereichert sind sowie die so erhaltenen peptidfraktionen
10/12/1994EP0471011B1 HUMAN LACTOFERRIN cDNA SEQUENCE
10/12/1994EP0434713B1 Hiv-1 envelope muteins lacking hypervariable domains
10/12/1994CN1093406A Isolated nucleic acid sequence coding for a tumor rejection antigen precursor processed to at least one tumor rejection antigen presented by HLA-A2
10/11/1994US5354900 Diuretics, hypotensive agents
10/11/1994US5354848 Producing simple or substituted carbamylic amino groups, or substituted thiocarbamylic amino groups or substituted guanidino groups; hyposensitizing therapy
10/11/1994US5354847 Chimeric antibody with specificity to human tumor antigen
10/11/1994US5354846 Streptolysin O antigen derivatives, its production and uses
10/11/1994US5354845 FK-506 and rapamycin specific binding immunophilin
10/11/1994US5354843 Bone disorders; antiarthritic agents; medical diagnosis of thyroid cancer; automatic solid phase synthesis; resin peptides
10/11/1994US5354765 Synergistic
10/11/1994US5354738 Amino acid derivatives
10/11/1994US5354736 Synthetic compounds and compositions with enhanced cell binding
10/11/1994US5354691 Immunogens inducing resistance to autoimmune arthritis
10/11/1994US5354690 Immunological methods for the detection of the human type IV collagen α5 chain
10/11/1994US5354684 Agrobacterium radiobacter K84 carrying transfer-deficient pAgK84 plasmids
10/11/1994US5354678 Production of recombinant adeno-associated virus vectors
10/11/1994US5354666 Mammalian cell line expressing basement membrane proteins
10/11/1994US5354665 Recombinant DNA processes for producing PI-linked lymphocyte function associated antigen-3
10/11/1994US5354664 Anticoagulants
10/11/1994US5354661 Monoclonal antibody to enterohemorrhagic Escherichia coli 0157:H7 and 026:H11 and method for detection
10/11/1994US5354557 Unglycosylated polypeptide chains having disulfide bonding; peridontal or dental reconstruction, inducing bone formation
10/11/1994US5354555 Against Infectious Hematopoietic Necrosis virus
10/11/1994US5354269 Method for treating cancer resections
10/11/1994CA1332367C Method for the reduction of heterogeneity of monoclonal antibodies
10/11/1994CA1332366C Leukotoxin gene of pasteurella haemolytica
10/11/1994CA1332354C Pharmaceutical formulation for the treatment of diabetes mellitus
10/07/1994CA2120693A1 Polypeptide and dnas encoding it
10/06/1994DE4339922C1 Vector for gene therapy of the liver
10/06/1994DE4310643A1 Cyclic adhesion inhibitors
10/06/1994DE4310529A1 Monoclonal antibodies C10 and F1, antibody-producing hybridoma cells and use of the antibodies as markers for a resistance gene
10/05/1994EP0618294A1 Expression of pertussis holotoxin in bordetella pertussis
10/05/1994EP0618293A1 Human contactin, a cell adhesion molecule
10/05/1994EP0618292A1 CEA derivatives lacking the Hydrophobic C-terminal domain
10/05/1994EP0618291A2 PACAP receptor protein, method for preparing said protein, and use thereof
10/05/1994EP0618231A1 Immunologically active conjugates and a method for their preparation
10/05/1994EP0618230A1 Anti-metastatic factor
10/05/1994EP0618229A1 Amylase inhibitors
10/05/1994EP0618227A1 Biologically active polypeptide fusion dimers
10/05/1994EP0618226A1 Inhibitors of herpes viral ribonculeotide reductase
10/05/1994EP0618225A1 Linear adhesion inhibitors
10/05/1994EP0618220A1 Method for purifying interleukin-4
10/05/1994EP0618219A1 Procedure for obtaining carbocalcitonin
10/05/1994EP0617967A1 Therapeutic reagents based on unique sequences within the variable region of the T cell receptor
10/05/1994EP0617736A1 USE OF $i(BACILLUS THURINGIENSIS) ISOLATES FOR CONTROLLING PESTS IN THE FAMILY APHIDIDAE
10/05/1994EP0617626A1 Soybean protein or hydrolyzates in pharmaceutical compositions to protect bioactive peptides from enzymatic inactivation
10/05/1994EP0617614A1 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor
10/05/1994EP0602044A4 A cdna clone encoding a human norepineprhine transporter.
10/05/1994EP0576590A4 Response element compositions and assays employing same
10/05/1994EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use
10/05/1994EP0232326B1 Inhibin and method of purifying same
10/05/1994CN1093090A Cyclopeptides
10/04/1994US5352815 Agent for suppression and interception of mailard reaction
10/04/1994US5352779 N-linked oligosaccharide chain of glycoprotein coded by DNA molecule eliminated from amino acid position 52 and/or 78 of the alpha subunit
10/04/1994US5352775 Diagnosis, therapy cancer
10/04/1994US5352772 75 Kilodalton interleukin-2 receptor proteins and their uses
10/04/1994US5352770 Porcine derived novel physiologically active peptide
10/04/1994US5352769 Genetic engineering
10/04/1994US5352668 Product and method for improving keratinocyte adhesion to the dermis
10/04/1994US5352664 Thrombin derived polypeptides; compositions and methods for use
10/04/1994US5352662 Injectable extended release formulations and methods